Results
1 -
10 of
11
(Click
here to explore results)
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 10 Glutamate Receptor Modulators as Emergent Therapeutic Agents in the Treatment of Parkinson’s Disease. Sylvain Célanire, Benjamin Perry, Robert Lutjens, Sonia Poli, Ian J. Reynolds
, 2013
, Pages 237-265
- Synthetic Methods in Drug Discovery: Volume 1, Chapter 7 Chan–Lam Coupling Reaction: Copper-promoted C–Element Bond Oxidative Coupling Reaction with Boronic Acids. Patrick Y. S. Lam
, 2016
, Volume 1
, Pages 242-273
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 5 Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease. Mildred D. Gottwald, Michael J. Aminoff
, 2013
, Pages 110-125
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Ion Channel Drug Discovery, CHAPTER 1 Ion Channel Drug Discovery: a Historical Perspective. Brian Cox
, 2015
, Pages 1-15
- Ion Channel Drug Discovery, CHAPTER 3 Automated Electrophysiology in Ion Channel Drug Discovery. John Dunlop
, 2015
, Pages 42-55
- Synthetic Methods in Drug Discovery: Volume 2, Subject Index
, 2016
, Volume 2
, Pages 505-517
- Synthetic Methods in Drug Discovery: Volume 1, Subject Index
, 2016
, Volume 1
, Pages 443-455
- Emerging Drugs and Targets for Parkinson's Disease, Subject Index
, 2013
, Pages 390-402
- Ion Channel Drug Discovery, CHAPTER 13 Antibodies as Ion Channel Modulators. Wilson Edwards, Alan D. Wickenden
, 2015
, Pages 320-340